Koers Stereotaxis Inc OTC Bulletin Board
Aandelen
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
||
- USD | - |
|
Omzet 2024 * | 30,4 mln. 27,94 mln. | Omzet 2025 * | 43,6 mln. 40,07 mln. | Marktkapitalisatie | 165 mln. 152 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -18 mln. -16,54 mln. | Nettowinst (verlies) 2025 * | -15 mln. -13,78 mln. | EV/omzet 2024 * | 5,43 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 3,79 x |
K/w-verhouding 2024 * |
-8,38
x | K/w-verhouding 2025 * |
-9,14
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,16% |
Recentste transcriptie over Stereotaxis Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Fischel
CEO | Chief Executive Officer | 57 | 29-09-16 |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 01-01-03 |
Laura Garth
LAW | General Counsel | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 01-05-05 |
David Fischel
CEO | Chief Executive Officer | 57 | 29-09-16 |
Nathan Fischel
BRD | Director/Board Member | 68 | 03-02-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,62% | 208 mld. | |
+6,44% | 182 mld. | |
+29,61% | 155 mld. | |
+34,96% | 115 mld. | |
+2,66% | 66,52 mld. | |
+17,38% | 53,93 mld. | |
-4,51% | 46,26 mld. | |
-5,77% | 38,22 mld. | |
+3,71% | 36,6 mld. |
- Beurs
- Aandelen
- Koers STXS
- Koers